Original Research
Published on 26 Sep 2022
Mutant p53K120R expression enables a partial capacity to modulate metabolism
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.974662
- 2,359 views
- 2 citations
Type at least 3 characters
1,029 articles
Articles
Original Research
Published on 26 Sep 2022
Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.998792
- 3,364 views
- 3 citations
Original Research
Published on 26 Sep 2022
Cuproptosis patterns and tumor microenvironment in endometrial cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1001374
- 4,505 views
- 4 citations
Original Research
Published on 26 Sep 2022
Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.969856
- 5,389 views
- 11 citations
Original Research
Published on 26 Sep 2022
The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.977322
- 8,809 views
- 34 citations
Original Research
Published on 26 Sep 2022
Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.866340
- 2,633 views
- 1 citation
Original Research
Published on 23 Sep 2022
Application of RNA processing factors for predicting clinical outcomes in colon cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.979001
- 1,843 views
Mini Review
Published on 23 Sep 2022
Epigenetic factors in breast cancer therapy
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.886487
- 5,150 views
- 5 citations
Original Research
Published on 23 Sep 2022
Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.972212
- 5,677 views
- 10 citations
Original Research
Published on 23 Sep 2022
An oxidative stress-related prognostic signature for indicating the immune status of oral squamous cell carcinoma and guiding clinical treatment
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.977902
- 2,653 views
- 5 citations
Original Research
Published on 21 Sep 2022
Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.988821
- 2,986 views
- 8 citations
Original Research
Published on 21 Sep 2022
FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1017762
- 3,423 views
- 7 citations
Original Research
Published on 21 Sep 2022
Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.988433
- 2,172 views
- 2 citations
Original Research
Published on 21 Sep 2022
A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.948254
- 2,094 views
- 3 citations
Original Research
Published on 21 Sep 2022
A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1016449
- 2,133 views
- 2 citations
Original Research
Published on 21 Sep 2022
Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.948920
- 2,779 views
- 2 citations